GW29-e1538 Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry Program

Chang-Sheng Ma,Young-Hoon Kim,Yorihiko Higashino,Evgeny Shlyakhto,Sergio Dubner,Jonathan L. Halperin,Kenneth J. Rothman,Shihai Lu,Lionel Riou França,Miney Paquette,Christine Teutsch,Menno V. Huisman,Gregory Y.H. Lip

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 0|浏览67

暂无评分

摘要

With the rising prevalence of atrial fibrillation in an aging population, rates of AF-associated stroke are increasing. The availability of non-vitamin K antagonist oral anticoagulants (NOACs) has changed stroke prevention in AF, based on clinical trial evidence showing that these agents are safer

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要